lbs; p¼.52) nor GWG within/below guidelines (50.8% vs 47.7%; p¼.73) differed between the intervention group and usual care. Results were unchanged when only obese women were included in the analysis. There was a trend towards fewer cases of large for gestational age neonates in the intervention group (11% vs 28%; p¼.07) among obese women. CONCLUSION: An intensive behavioral intervention did not improve adherence to GWG guidelines in overweight and obese gravidas. These data suggest that antenatal modifications to GWG may be limited and highlights the importance of prepregnancy weight loss. Novel approaches are needed to optimize GWG in overweight and obese women.
OBJECTIVE: Response to medications and pregnancy outcomes vary in women with gestational diabetes mellitus (GDM). We sought to describe subtypes of GDM based on mechanisms of hyperglycemia and assess the frequency of adverse pregnancy outcomes. STUDY DESIGN: We performed a prospective cohort study of 111 pregnant women with singleton gestation at 24-30 weeks' undergoing oral glucose tolerance testing. We estimated insulin sensitivity and secretion using the Matsuda and Stumvoll index, respectively. Low insulin sensitivity or secretion were defined using values below the 25 th percentile as established in women with normal glucose tolerance. Women with GDM (n¼33) were divided into the subtypes of insulin resistance, insulin secretion deficiency, or a combination of both. RESULTS: Predominant insulin resistance occurred in 45%, predominant insulin secretion deficiency in 33%, and combined insulin resistance and insulin secretion deficiency defects in 21% of women with GDM. Relative to women with normal glucose tolerance, those with combined defects had higher pre-pregnancy BMI (36.3 AE 12.8 vs.28.5 AE 6.4, p¼ 0.01) and fasting glucose (106.7 AE 23.5 vs. 82.9 AE 9.7, p<0.0001), larger infants (birth weight 3445.4 AE 627.2 vs. 3178.9 AE 571.2, p¼ 0.001), and greater risk of GDM-associated adverse neonatal outcomes (57.1 vs. 15.4%, p¼0.01) (Table) . Differences in neonatal outcomes were independent of BMI. By comparison, women with predominant insulin secretion deficiency had maternal characteristics similar to women with normal glucose tolerance, except for higher triglycerides (248.7 AE 73.6 vs. 189.1 AE 69, p¼0.02) and a higher risk of adverse neonatal outcomes (45.5 vs. 15.4%, p¼0.01). CONCLUSION: Heterogeneity of mechanistic processes underlying hyperglycemia exists among women with GDM. Further studies are needed to explore the impact of GDM subtypes on treatment response.
